Home> Products> pulmonary embolism thrombus prevention

{ "products": [ { "_id": "69df3ef834127e7b656ef646", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivaroxaban 2.5 mg", "description": "ROXARIVABEN 2.5 is a clinically trusted formulation of Rivaroxaban 2.5 mg, an advanced oral anticoagulant widely used for the prevention and management of thromboembolic disorders. It belongs to a class of medicines known as direct Factor Xa inhibitors, which work by preventing the formation of harmful blood clots in the body.\n\nBlood clot-related conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and cardiovascular complications can be life-threatening if not treated effectively. ROXARIVABEN 2.5 is specifically designed to reduce these risks by maintaining smooth blood flow and minimizing clot formation without the need for frequent monitoring like traditional anticoagulants.\n\nThis product is increasingly prescribed by healthcare professionals due to its predictable action, convenience, and proven efficacy in improving patient outcomes.\n\nHow Rivaroxaban 2.5 mg Works\n\nRivaroxaban works by selectively blocking Factor Xa, an essential enzyme in the blood coagulation process. Factor Xa plays a crucial role in converting prothrombin into thrombin, which ultimately leads to clot formation.\n\nBy inhibiting this step:\n\nIt reduces thrombin generation\nPrevents fibrin clot formation\nMaintains smooth blood circulation\n\nUnlike older anticoagulants, Rivaroxaban provides targeted action, minimizing complications while ensuring effective clot prevention.\n\nUses of ROXARIVABEN 2.5\n\nROXARIVABEN 2.5 is prescribed for multiple cardiovascular and thrombotic conditions. Some of its key uses include:\n\n1. Prevention of Cardiovascular Events\n\nIt is commonly used in patients with:\n\nCoronary artery disease (CAD)\nPeripheral artery disease (PAD)\n\nIt helps reduce the risk of:\n\nHeart attacks\nStroke\nCardiovascular death\n2. Deep Vein Thrombosis (DVT)\n\nPrevents and treats blood clots that form in deep veins, usually in the legs.\n\n3. Pulmonary Embolism (PE)\n\nUsed to prevent clots from traveling to the lungs, which can be life-threatening.\n\n4. Post-Surgical Clot Prevention\n\nRecommended after major surgeries (like knee or hip replacement) to prevent clot formation.\n\n5. Secondary Prevention\n\nHelps prevent recurrence of clotting events in high-risk patients.\n\nKey Benefits of ROXARIVABEN 2.5\n1. Effective Anticoagulation\n\nProvides reliable prevention against clot formation with a targeted mechanism of action.\n\n2. No Routine Monitoring Required\n\nUnlike warfarin, it does not require frequent INR monitoring, making it more convenient for patients.\n\n3. Predictable Pharmacokinetics\n\nOffers consistent and predictable results, reducing dose adjustments.\n\n4. Reduced Risk of Stroke & Heart Attack\n\nSignificantly lowers the chances of major cardiovascular events in high-risk individuals.\n\n5. Oral Administration\n\nEasy-to-take tablet form improves patient compliance compared to injectable anticoagulants.\n\n6. Rapid Onset of Action\n\nBegins working quickly after administration, providing faster protection.\n\n7. Lower Drug & Food Interactions\n\nHas fewer dietary restrictions compared to traditional anticoagulants.\n\nDosage and Administration\nThe typical dose is Rivaroxaban 2.5 mg, taken as prescribed by a healthcare professional.\nUsually taken twice daily with food for optimal absorption.\nDosage may vary depending on the condition and patient profile.\nImportant Guidelines:\nTake the medicine at the same time each day\nDo not skip doses\nDo not stop medication without consulting a doctor\nIf a dose is missed, take it as soon as remembered unless it’s close to the next dose\nSide Effects of ROXARIVABEN 2.5\n\nLike all medications, ROXARIVABEN 2.5 may cause some side effects. Most are mild, but some may require medical attention.\n\nCommon Side Effects:\nBleeding (minor bruising, nosebleeds)\nNausea\nHeadache\nDizziness\nModerate Side Effects:\nProlonged bleeding from cuts\nBlood in urine or stools\nFatigue or weakness\nSerious Side Effects (Seek Immediate Medical Help):\nSevere or uncontrolled bleeding\nVomiting blood or coughing blood\nSudden severe headache\nDifficulty breathing\nPrecautions and Warnings\n1. Bleeding Risk\n\nAs an anticoagulant, it increases the risk of bleeding. Patients should:\n\nAvoid activities with injury risk\nInform doctors before surgeries or dental procedures\n2. Kidney & Liver Conditions\n\nUse with caution in patients with:\n\nKidney impairment\nLiver disease\n3. Drug Interactions\n\nInform your doctor if you are taking:\n\nOther blood thinners\nNSAIDs\nCertain antibiotics or antifungals\n4. Pregnancy & Breastfeeding\nNot recommended unless prescribed\nConsult a doctor before use\n5. Elderly Patients\n\nMay require careful monitoring due to increased bleeding risk.\n\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nWhy Choose ROXARIVABEN 2.5?\n\nROXARIVABEN 2.5 stands out in the anticoagulant segment due to its:\n\nProven efficacy in cardiovascular protection\nEase of use and patient compliance\nMinimal monitoring requirements\nStrong safety and tolerability profile\n\nIt is an ideal choice for long-term management of thrombotic conditions and cardiovascular risk reduction.\n\nConclusion\nROXARIVABEN 2.5 (Rivaroxaban 2.5 mg) is a modern, reliable, and highly effective anticoagulant that plays a crucial role in preventing life-threatening clot-related complications. With its targeted mechanism, ease of administration, and reduced need for monitoring, it has become a preferred choice among healthcare professionals and patients alike.", "price": 117.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2379, "imageuri": "https://productimages.withfloats.com/actual/69df3f35d87dd0c2a3208b9c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69df3f35d87dd0c2a3208b9c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-15T07:32:08.559Z", "updatedon": "2026-04-15T08:04:06.502Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rivaroxaban-2-5-mg/2379", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROXARIVABEN 2.5", "category": "CARDIOLOGYRANGE", "tags": [ "rivaroxaban 2.5 mg", "rivaroxaban 2.5 mg uses in hindi", "rivaroxaban 2.5 mg uses", "rivaroxaban 2.5 mg tablet", "rivaroxaban 2.5 mg price", "tab rivaroxaban 2.5 mg uses", "rivaroxaban 2.5 mg tablet uses", "rivaroxaban 2.5 mg tablet", "rivaroxaban 2.5 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nicoumalone 4 mg", "description": "NICOMALOM 4 \nNicoumalone (4 mg)\nIntroduction:\nNICOMALOM 4 is a prescription medicine containing Nicoumalone 4 mg, an oral anticoagulant widely used to prevent and treat harmful blood clots. Blood clot formation inside blood vessels can interrupt normal blood flow and lead to serious, life-threatening conditions such as stroke, heart attack, pulmonary embolism, and deep vein thrombosis. NICOMALOM 4 plays a crucial role in reducing these risks by maintaining proper blood fluidity and preventing abnormal clot formation.\n\nNicoumalone has been used for decades in clinical practice and is trusted by physicians for long-term anticoagulation therapy. NICOMALOM 4 is commonly prescribed to patients with heart valve disorders, atrial fibrillation, a history of thrombosis, or post-surgical clot risk. With careful monitoring and proper dosage, NICOMALOM 4 offers dependable protection and improved quality of life.\n\nComposition\n\nEach tablet contains:\n\nNicoumalone IP 4 mg\n\nUses of NICOMALOM 4 Tablet\n\nNICOMALOM 4 is prescribed for the prevention and treatment of thromboembolic disorders. Its key uses include:\n\n1. Prevention of Blood Clots\n\nNICOMALOM 4 helps prevent the formation of dangerous clots in veins and arteries, reducing the risk of blockages that can impair blood supply to vital organs.\n\n2. Deep Vein Thrombosis (DVT)\n\nIt is used in patients with existing or previous DVT to prevent clot extension and recurrence.\n\n3. Pulmonary Embolism (PE)\n\nNICOMALOM 4 helps prevent clots from traveling to the lungs, a potentially fatal complication.\n\n4. Atrial Fibrillation\n\nPatients with irregular heart rhythms are at high risk of clot formation. NICOMALOM 4 reduces the risk of stroke associated with atrial fibrillation.\n\n5. Heart Valve Disorders\n\nIt is commonly prescribed for patients with mechanical heart valves to prevent clot formation on valve surfaces.\n\n6. Post-Surgical Thrombosis Prevention\n\nNICOMALOM 4 is used after major surgeries, especially orthopedic and cardiac procedures, to prevent postoperative clot formation.\n\nHow NICOMALOM 4 Works\n\nNicoumalone belongs to the class of drugs known as Vitamin K antagonists. Vitamin K plays a vital role in the synthesis of clotting factors in the liver. NICOMALOM 4 works by inhibiting the action of Vitamin K, thereby reducing the production of clotting factors II, VII, IX, and X.\n\nThis leads to:\n\nSlower clot formation\n\nPrevention of new clots\n\nReduced growth of existing clots\n\nImproved blood flow through vessels\n\nIts mechanism ensures effective anticoagulation while allowing careful dose adjustment based on laboratory monitoring.\n\nKey Benefits of NICOMALOM 4\n✔ Effective Long-Term Anticoagulation\n\nNICOMALOM 4 provides sustained prevention against clot formation when taken regularly under medical supervision.\n\n✔ Reduces Risk of Stroke and Heart Attack\n\nBy preventing clot-related blockages, it significantly lowers the risk of ischemic stroke and cardiac complications.\n\n✔ Essential for Heart Valve Patients\n\nA preferred therapy for patients with mechanical heart valves requiring lifelong anticoagulation.\n\n✔ Prevents Recurrence of Thrombosis\n\nReduces the chances of clot recurrence in patients with a history of DVT or PE.\n\n✔ Cost-Effective and Clinically Proven\n\nNicoumalone is a well-established and affordable anticoagulant with proven efficacy.\n\n✔ Flexible Dosing\n\nDosage can be adjusted based on INR values to achieve optimal therapeutic outcomes.\n\nDosage and Administration\n\nThe dosage of NICOMALOM 4 varies depending on the patient’s medical condition, age, body weight, and INR levels.\n\nUsually taken once daily, preferably at the same time each day\n\nCan be taken with or without food\n\nTablets should be swallowed with water\n\n⚠ Regular INR monitoring is mandatory to maintain safe and effective anticoagulation.\n\nPossible Side Effects of NICOMALOM 4\n\nLike all anticoagulants, NICOMALOM 4 may cause side effects, most of which are related to bleeding.\n\nCommon Side Effects:\n\nEasy bruising\n\nNosebleeds\n\nBleeding gums\n\nProlonged bleeding from cuts\n\nModerate Side Effects:\n\nBlood in urine or stool\n\nHeavy or prolonged menstrual bleeding\n\nGastrointestinal discomfort\n\nSerious Side Effects (Seek medical attention immediately):\n\nSevere bleeding\n\nBlack or tarry stools\n\nSudden weakness or dizziness\n\nSevere headache or difficulty speaking\n\nPrecautions and Warnings\n\nNICOMALOM 4 should not be used without medical supervision\n\nAvoid sudden changes in Vitamin K intake (green leafy vegetables)\n\nInform your doctor about all medicines and herbal supplements you are taking\n\nUse caution in patients with liver disease, bleeding disorders, or peptic ulcers\n\nNot recommended during pregnancy due to risk of fetal harm\n\nAlcohol consumption should be limited\n\nDrug Interactions\n\nNICOMALOM 4 can interact with:\n\nAntibiotics\n\nPainkillers (NSAIDs)\n\nAntifungal medications\n\nHerbal products like ginseng or garlic\n\nAlways consult your doctor before starting or stopping any medication.\n\nStorage Instructions\n\nStore in a cool, dry place\n\nProtect from light and moisture\n\nKeep out of reach of children\n\nConclusion\n\nNICOMALOM 4 (Nicoumalone 4 mg Tablet) is a highly effective and trusted oral anticoagulant used to prevent and manage serious thromboembolic conditions. Its proven mechanism of action, flexibility in dosing, and long-term clinical use make it an essential therapy for patients at risk of blood clot-related complications.\n", "price": 365.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2026-03-13T06:03:24.442Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicoumalone-4-mg/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "nicoumalone 4 mg tablet price", "nicoumalone tablet uses in hindi", "nicoumalone 4mg", "nicoumalone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nicoumalone 2mg", "description": "NICOMALOM 2 \nNICOMALOM 2 features Nicoumalone, also known as Acenocoumarol, as its active ingredient in a 2mg tablet formulation. This medication belongs to the coumarin class of anticoagulants, which work by interfering with the liver's production of vitamin K-dependent clotting factors like II, VII, IX, and X. Unlike newer direct oral anticoagulants, NICOMALOM 2 offers a well-established profile with adjustable dosing based on individual INR monitoring, ideal for personalized treatment plans. Each tablet is crafted for easy oral administration, typically once daily, ensuring consistent blood thinning without the need for injections.\n​\n\nThe formulation ensures rapid absorption, with peak effects within hours, allowing for effective clot prevention in high-risk scenarios. Steris Healthcare emphasizes quality manufacturing standards, making NICOMALOM 2 suitable for adults managing chronic conditions or post-surgical recovery. Its compact packaging of 10 tablets per strip supports convenient storage and portability for ongoing therapy.\n​\n\nKey Uses\nNICOMALOM 2 excels in preventing and treating thromboembolic disorders where blood clots pose immediate dangers. Primary applications include deep vein thrombosis (DVT), where clots form in deep leg veins, and pulmonary embolism (PE), a potentially fatal blockage in lung arteries. Physicians also prescribe it to reduce stroke risk in patients with atrial fibrillation, a common irregular heartbeat that promotes clot formation in the heart.\n​\n\nBeyond these, NICOMALOM 2 prevents clots after surgeries like hip or knee replacements, or in those with mechanical heart valves. It supports prophylaxis in recurrent clotting episodes, ensuring smoother blood flow and oxygen delivery to vital organs. For patients in Jaipur and Rajasthan facing high incidences of cardiovascular issues due to lifestyle factors, this medication provides targeted protection tailored to regional healthcare needs.\n​\n\nMechanism of Action\nNICOMALOM 2 disrupts the clotting cascade by blocking vitamin K epoxide reductase, an enzyme essential for regenerating vitamin K. This inhibition halts the activation of prothrombin and other coagulation factors, thinning the blood and preventing new clot formation while allowing existing ones to dissolve naturally. The result is improved vascular patency, reducing symptoms like leg swelling in DVT or breathlessness in PE.\n​\n\nTherapeutic levels are maintained through regular INR testing, typically targeting 2.0-3.0 for most indications, which differentiates it from fixed-dose alternatives. This precise control minimizes over-anticoagulation risks, making it suitable for long-term use in diverse patient profiles, including the elderly under careful supervision.\n​\n\nKey Benefits\nPatients using NICOMALOM 2 experience significant reductions in clot-related hospitalizations, with studies showing up to 80% lower stroke incidence in atrial fibrillation cases. Its oral convenience enhances adherence compared to injectables, promoting better quality of life for those with mobility limitations post-surgery. Cost-effectiveness positions it as an accessible option in India's pharmaceutical market, especially for Steris Healthcare clients optimizing SEO-driven healthcare content.\n​\n\nAdditional advantages include reversibility with vitamin K administration in emergencies and compatibility with dietary adjustments for stable INR. For pharmaceutical marketers, NICOMALOM 2's established safety data supports strong branding in neurology and cardiology segments, driving patient trust and repeat prescriptions.\n​\n\nBenefit\tDescription\tClinical Impact \n​\nStroke Prevention\tLowers risk in atrial fibrillation by 60-70%\tFewer neurological emergencies\nPost-Surgical Protection\tReduces thromboembolism after orthopedic procedures\tShorter recovery times\nDVT/PE Management\tHalts clot progression effectively\tImproved mobility and oxygenation\nLong-Term Safety\tAdjustable dosing via INR monitoring\tSustained therapy without frequent switches\nAffordability\tCompetitive pricing in Indian market\tHigh accessibility for diverse demographics\nPotential Side Effects\nWhile effective, NICOMALOM 2 carries bleeding risks as its primary concern, including easy bruising, gum bleeding, or prolonged cuts. Common gastrointestinal issues like nausea, vomiting, or diarrhea affect some users, often manageable by taking with food. Less frequent effects encompass hair loss, skin rashes, or itching, which typically resolve with dose adjustments.\n​\n\nRare but serious reactions involve heavy menstrual bleeding, nosebleeds, or internal hemorrhage signaled by black stools or blood in urine—prompt medical attention is crucial. Elderly patients or those with liver/kidney impairment face heightened sensitivity, necessitating baseline assessments. Interactions with antibiotics, NSAIDs, or vitamin K-rich foods like spinach can amplify effects, underscoring the need for holistic patient education.\n​\nSide Effect Category\tExamples\tManagement Tips \n​\nCommon (Mild)\tBruising, nausea, diarrhea\tTake with meals; monitor diet\nSerious (Bleeding)\tNosebleeds, heavy periods, wounds\tSeek immediate care; INR checks\nRare\tHair loss, rash, appetite loss\tDose tweak; symptomatic relief\nDrug/Food Interactions\tWarfarin-like potentiators, greens\tInform doctor of all intake\nDosage and Safety Precautions\nStandard initial dosing starts at 2-4 mg daily, titrated per INR response, often 1-10mg maintenance. Children and the elderly require caution with lower starts. Avoid abrupt stops to prevent rebound clotting; inform surgeons/dentists pre-procedure. Pregnant or breastfeeding women should consult alternatives due to fetal risks.\n​\nRegular prothrombin time tests ensure efficacy, with lifestyle advice like avoiding contact sports minimizing injury. Store at room temperature, away from moisture.\n​\nConclusion\nNICOMALOM 2 delivers robust anticoagulation for clot prevention, balancing potent benefits against manageable risks through vigilant monitoring. For patients and healthcare providers in pharmaceutical hubs like Jaipur, it remains a cornerstone therapy, enhancing outcomes in DVT, PE, and beyond. Always prioritize professional guidance for optimal results.", "price": 227.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2026-03-13T05:57:23.788Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicoumalone-2mg/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ec40a870e7b20c49e1d60", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROXARIVABEN 15", "description": "ROXARIVABEN 15\nRivaroxaban (15mg)\nIt seems there might be a small discrepancy in the dosage you provided, as Rivaroxaban is typically available in dosages of 2.5mg, 10mg, 15mg, and 20mg. However, it's essential to adhere strictly to the dosage prescribed by your healthcare provider.\n\nRivaroxaban, the active ingredient in Roxarivaben 15 (assuming it's available in that dosage), is an anticoagulant medication used to prevent and treat blood clots. It works by inhibiting the activity of certain clotting proteins in the blood, thus reducing the risk of blood clot formation.\n\nRivaroxaban is commonly prescribed for conditions such as atrial fibrillation (an irregular heart rhythm), prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of DVT and PE in patients undergoing certain types of surgery.\n\nAs with any anticoagulant medication, it's crucial to take Rivaroxaban exactly as prescribed by your healthcare provider and to follow their instructions closely. It's also important to inform your healthcare provider about any other medications or supplements you're taking, as they can interact with Rivaroxaban and affect its effectiveness or increase the risk of side effects. If you have any questions or concerns about Roxarivaben 15 or its usage, don't hesitate to consult with your healthcare provider for personalized advice. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/roxarivaben-15-133371", "price": 350.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "20mg", "risk", "15mg", "10mg", "Email", "usage", "2.5mg", "types", "dosage", "stroke", "surgery", "patients", "concerns", "WhatsApp", "activity", "questions", "treatment", "prevention", "conditions", "blood clots", "ROXARIVABEN", "Rivaroxaban", "supplements", "information", "instructions", "sterispharma", "sterisonline", "side effects", "effectiveness", "other medications", "systemic embolism", "clotting proteins", "active ingredient", "small discrepancy", "pulmonary embolism", "healthcare provider", "personalized advice", "blood clot formation", "deep vein thrombosis", "anticoagulant medication", "an irregular heart rhythm", "nonvalvular atrial fibrillation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1269, "imageuri": "https://productimages.withfloats.com/actual/665ec412c62090b80544c885.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665ec412c62090b80544c885.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T07:36:42.081Z", "updatedon": "2026-03-16T11:33:36.798Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//roxarivaben-15/1269", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rivaroxaban (15mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ec24b870e7b20c49e1c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROXARIVABEN 10", "description": "ROXARIVABEN 10\nRivaroxaban (10mg)\nRoxarivaben 10 is a medication containing the active ingredient Rivaroxaban, with a dosage strength of 10mg.\n\nRivaroxaban is an anticoagulant, or blood thinner, that works by inhibiting the activity of certain clotting proteins in the blood. It is commonly used for various medical conditions, including the prevention of blood clots in patients with atrial fibrillation (an irregular heart rhythm), the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) after certain surgeries, and the treatment and prevention of DVT and PE.\n\nAs with any anticoagulant medication, it's crucial to take Rivaroxaban exactly as prescribed by a healthcare professional and to follow their instructions closely. Improper use or sudden discontinuation of anticoagulants can increase the risk of bleeding or lead to other complications. If you have any questions or concerns about Roxarivaben 10 or its usage, it's important to consult with a healthcare provider for personalized advice and guidance.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/roxarivaben-10-133370", "price": 252.0, "discountamount": 76.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "10mg", "risk", "Call", "Email", "usage", "WhatsApp", "guidance", "concerns", "patients", "bleeding", "activity", "surgeries", "treatment", "questions", "prevention", "blood clots", "ROXARIVABEN", "Rivaroxaban", "information", "instructions", "sterispharma", "sterisonline", "Improper use", "blood thinner", "anticoagulants", "dosage strength", "active ingredient", "clotting proteins", "pulmonary embolism", "atrial fibrillation", "other complications", "healthcare provider", "personalized advice", "deep vein thrombosis", "irregular heart rhythm", "sudden discontinuation", "healthcare professional", "anticoagulant medication", "various medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1268, "imageuri": "https://productimages.withfloats.com/actual/665ec258947ffd864ebbb5f0.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ec258947ffd864ebbb5f0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T07:29:15.949Z", "updatedon": "2026-03-13T12:41:42.725Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//roxarivaben-10/1268", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rivaroxaban (10mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665db7b2a743fd235821cb30", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Apixaban 5mg", "description": "APIXAZEN 5 \nAPIXAZEN 5 is a branded pharmaceutical formulation containing apixaban 5 mg as its active ingredient. It belongs to a modern class of anticoagulant medications known as Factor Xa inhibitors'—also referred to as 'direct oral anticoagulants (DOACs). ' Unlike traditional blood thinners such as warfarin, Apixaban works by selectively blocking Factor Xa, a crucial enzyme in the coagulation cascade, thereby preventing the formation of dangerous blood clots.\n\nBlood clots, when formed within veins or arteries, can travel to critical organs such as the lungs, brain, or heart—causing life-threatening events like pulmonary embolism, stroke, or deep vein thrombosis (DVT). APIXAZEN 5 is clinically indicated to reduce this risk in a wide range of patients, making it one of the most widely prescribed anticoagulants in contemporary cardiovascular medicine.\n\nEach film-coated tablet of APIXAZEN 5 contains exactly 5 milligrams of Apixaban and is designed for convenient twice-daily oral administration, with or without food. Its predictable pharmacokinetics and minimal drug-food interactions make it significantly more patient-friendly than older anticoagulant alternatives.\nWho Should Not Take APIXAZEN 5?\nAPIXAZEN 5 is contraindicated in the following conditions:\n\nPatients with known hypersensitivity to Apixaban or any excipients should not use this medication. It is contraindicated in patients with active clinically significant bleeding, hepatic disease associated with coagulopathy, and in those with prosthetic heart valves or haemodynamically significant rheumatic heart disease. APIXAZEN 5 is not recommended during pregnancy or breastfeeding unless clearly indicated by a physician. Concomitant use with other anticoagulants should be avoided except during transitions between therapies.\n\nFinal Assessment\n\nConclusion\nAPIXAZEN 5 (Apixaban 5mg) represents a significant advancement in oral anticoagulation therapy. As a selective, reversible inhibitor of Factor Xa, it delivers clinically proven protection against stroke, deep vein thrombosis, and pulmonary embolism — conditions that remain among the leading causes of morbidity and mortality worldwide.\n\nIts superior safety profile compared to traditional anticoagulants like warfarin — particularly its reduced risk of intracranial bleeding—combined with the absence of routine monitoring requirements and dietary restrictions, has made APIXAZEN 5 a preferred choice among cardiologists and haematologists globally.\n\nThe APIXAZEN 5 brand is formulated to meet the highest pharmaceutical standards, ensuring consistent bioavailability and reliable therapeutic outcomes for patients across a spectrum of cardiovascular and thromboembolic conditions. Whether used for long-term stroke prevention in atrial fibrillation or for short-term post-surgical thromboprophylaxis, this medication has a well-established evidence base supporting its efficacy and tolerability.\n\nAs with all prescription anticoagulants, APIXAZEN 5 must be taken strictly under the guidance of a qualified healthcare professional. Patients are encouraged to adhere to prescribed dosing schedules, report any unusual bleeding symptoms promptly, and keep all follow-up appointments. When used appropriately, APIXAZEN 5 can meaningfully reduce the burden of clot-related disease and significantly improve quality of life.\n", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PE", "DVT", "risk", "food", "need", "legs", "EMAIL", "doses", "class", "drugs", "DOACs", "water", "lungs", "safety", "stroke", "Action", "product", "surgery", "patients", "Overview", "Benefits", "APIXAZEN", "warfarin", "schedule", "Mechanism", "Treatment", "Adherence", "selective", "conversion", "Guidelines", "same times", "one tablet", "full glass", "key enzyme", "deep veins", "blood clots", "Optimal Use", "prothrombin", "information", "Consistency", "Apixaban 5mg", "crucial role", "instructions", "Introduction", "sterispharma", "fibrin clots", "best results", "sterisonline", "typical dose", "harmful clots", "CALL/WHATSAPP", "Medical Advice", "safer blood flow", "serious condition", "systemic embolism", "Recommended Dosage", "pulmonary embolism", "thrombin formation", "coagulation cascade", "Predictable Effects", "individual response", "essential component", "healthcare provider", "Oral Administration", "Embolism Prevention", "reversible inhibitor", "other anticoagulants", "Factor Xa Inhibition", "blood clot formation", "deep vein thrombosis", "thromboembolic events", "optimal effectiveness", "blood clot development", "convenient alternative", "Consistent blood levels", "anticoagulant medication", "routine blood monitoring", "other medical conditions", "severe respiratory issues", "effective anticoagulation", "injectable anticoagulants", "blood coagulation process", "direct oral anticoagulants", "valvular atrial fibrillation", "common heart rhythm disorder", "predictable anticoagulant effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1251, "imageuri": "https://productimages.withfloats.com/actual/665db7d4480b81124f842847.png", "tileimageuri": "https://productimages.withfloats.com/tile/665db7d4480b81124f842847.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:31:46.903Z", "updatedon": "2026-04-06T10:35:35.143Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//apixaban-5mg/1251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "APIXAZEN 5 ", "category": "DIABETIC RANGE", "tags": [ "apixaban 5mg", "apixaban 5mg tablet", "apixaban 5mg uses", "apixaban 5mg price", "apixaban 5mg tablet uses", "apixaban 5mg side effects", "tab apixaban 5mg", "side effect of apixaban 5mg", "apixaban 5mg uses in hindi", "tab apixaban 5mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b6418daf7a411d0a8fb0a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROXARIVABEN 15 ", "description": "ROXARIVABEN 15 \nRivaroxaban (15mg)\nROXARIVABEN 15 is a medication primarily used for the prevention of stroke and systemic embolism in individuals with non-valvular atrial fibrillation. It is also commonly prescribed to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly after knee or hip replacement surgery. This anticoagulant works by selectively inhibiting Factor Xa, an important component in the blood clotting process. By blocking this factor, ROXARIVABEN 15 effectively reduces the likelihood of clot formation, thereby minimizing the risk of serious clotting events. It is taken orally, and its dosage may vary based on the patient's medical condition and response to treatment. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n\n", "price": 350.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PE", "DVT", "risk", "knee", "dosage", "stroke", "patient", "response", "treatment", "Factor Xa", "likelihood", "prevention", "medication", "ROXARIVABEN", "individuals", "Rivaroxaban", "anticoagulant", "clot formation", "medical condition", "systemic embolism", "pulmonary embolism", "important component", "deep vein thrombosis", "blood clotting process", "serious clotting events", "hip replacement surgery", "valvular atrial fibrillation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 740, "imageuri": "https://productimages.withfloats.com/actual/662b641a595dd467cb78450e.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/662b641a595dd467cb78450e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T08:21:44.395Z", "updatedon": "2026-03-16T11:33:43.79Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//roxarivaben-15-/740", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rivaroxaban (15mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a6def248b0777b5cb29791c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Propranolol Hydrochloride Sustained Release Capsules IP", "description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.", "price": 45.0, "discountamount": 14.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2490, "imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T13:05:40.676Z", "updatedon": "2026-08-01T13:05:40.676Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPASULES LA 40", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }